Population-based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study.
Antti S RannikkoMare LehtTuomas MirttiAnu KenttämiesTeemu TolonenIrina Rinta-KiikkaTuomas P KilpeläinenKari NatunenHans G LiljaTerho LehtimäkiJani RaitanenPaula KujalaJohanna RonkainenMika MatikainenAnssi PetasKimmo TaariTeuvo L J TammelaAnssi AuvinenPublished in: BJU international (2022)
The findings constitute proof of principle for our screening protocol, as we achieved a substantial detection rate for clinically significant cancer with few clinically insignificant cases. Participation, however, was suboptimal.